Licorice, Glycyrrhiza Glabra, Ext.
CAS 84775-66-6
Licorice, Glycyrrhiza Glabra, Ext. (CAS 84775-66-6) is a pharmaceutical compound with 0 bioactivity targets and 2 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
LICORICE, GLYCYRRHIZA GLABRA, EXT. is linked to DTXSID901041937 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Licorice, Glycyrrhiza Glabra, Ext. used for in pharmaceutical contexts?
Licorice, Glycyrrhiza Glabra, Ext. (CAS 84775-66-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Licorice, Glycyrrhiza Glabra, Ext.?
Licorice, Glycyrrhiza Glabra, Ext. has 2 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Acute kidney injury. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Licorice, Glycyrrhiza Glabra, Ext. also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Glycyrrhiza Glabra Root Extract with EU status "permitted".
What clinical phase is Licorice, Glycyrrhiza Glabra, Ext. in?
No phase 1-4 clinical development badge is rendered for Licorice, Glycyrrhiza Glabra, Ext. because the matched compound identifier rows do not contain a max-phase value.